- First vaccinations have now begun in Mali in a phase III trial of a malaria vaccine developed at the University of Oxford. Known as R21/Matrix-M, it recently showed efficacy of 77% over 12 months in a phase IIb trial. https://www.ox.ac.uk/news/2021-05-07-promising-malaria-vaccine-enters-final-stage-clinical-testing-west-africa 4 comments science
Linking pages
Related searches:
Search whole site: site:ox.ac.uk
Search title: Promising malaria vaccine enters final stage of clinical testing in West Africa | University of Oxford
See how to search.